Instem Presenting and Exhibiting at the American College of Toxicology Meeting, Florida
Instem to Present Latest Trends in Target Safety Assessment and Showcase Leading Preclinical Solutions and Outsourced Services
CONSHOHOCKEN, PA – October 22, 2018 - - Instem, a leading provider of IT solutions to the global life sciences market, is pleased to announce it will once again exhibit at the American College of Toxicology (ACT) Annual Meeting, taking place November 4–7, at Palm Beach County Convention Center, West Palm Beach, Florida.
Conference delegates can also join Instem’s Chief Scientific Officer, Dr. Gordon Smith Baxter, for an Exhibitor Hosted Presentation titled “Solving Target Safety Assessment Challenges”.
Visitors to Instem’s booth #217 can learn more about:
- Submit™ for SEND Management- the most widely adopted suite of software and outsourced study services deployed at over 80 client sites in 15 countries. Stop by and learn how to Submit with confidence™. Download a case study ahead of the event.
- Provantis® - the leading SaaS solution for preclinical study management, serving single users to multi-site clients. Provantis users also have access to the Provantis Academy, an intuitive, online learning solution. Visit us for a demonstration! Learn how clients have reduced preclinical time from hours to minutes, download the case study.
- KnowledgeScan™ - Using a combination of artificial intelligence and human expertise KnowledgeScan is a unique technology-enabled service that is setting new standards in Target Safety Assessment (TSA). Customers can make faster, better informed decisions on their drug targets as a result of high-quality, unbiased and evidence-based TSAs. Download the fact sheet.
Instem will also be holding the following Exhibitor Hosted Presentation:
Solving Target Safety Assessment Challenges
Wednesday, November 7
12:00 Noon–12:55 PM
Room 1D
Presented by: Dr. Gordon Smith Baxter, Chief Scientific Officer, Instem
Companies are under enormous pressure to quickly produce high-quality target risk assessments to make drug development decisions. During this session, we will look at current industry trends and how augmented intelligence, coupled with data mining technologies, are enhancing this area.
No advance registration is required. For more information about the session email tsa@instem.com or speak to Instem’s booth team throughout the exhibition at booth # 217
The ACT Annual Meeting is designed by and for members, with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the practice of toxicology.
The 39th Annual Meeting will include a wide-ranging scientific program, offering a unique opportunity for toxicologists preparing for the challenges and decisions that will affect public health and safety in years to come. For further information about ACT and their annual meeting visit https://www.actox.org/am/am2018/index.asp
About Instem
Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.
Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.
Press Contacts:
Instem
Julie Jones
julie.jones@instem.com
Tel: +44 (0) 1785 825600
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990